These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12499181)

  • 61. Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    Ahmed A; Jafri H; Lutsar I; McCoig CC; Trujillo M; Wubbel L; Shelton S; McCracken GH
    Antimicrob Agents Chemother; 1999 Apr; 43(4):876-81. PubMed ID: 10103194
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis.
    Lutsar I; Friedland IR; Jafri HS; Wubbel L; Ahmed A; Trujillo M; McCoig CC; McCracken GH
    J Antimicrob Chemother; 2003 Oct; 52(4):651-5. PubMed ID: 12951330
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Experimental pneumococcal meningitis: role of leukocytes in pathogenesis.
    Ernst JD; Decazes JM; Sande MA
    Infect Immun; 1983 Jul; 41(1):275-9. PubMed ID: 6862627
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Activity of LY333328 in experimental meningitis caused by a Streptococcus pneumoniae strain susceptible to penicillin.
    Gerber J; Smirnov A; Wellmer A; Ragheb J; Prange J; Schütz E; Wettich K; Kalich S; Nau R
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2169-72. PubMed ID: 11408247
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows.
    Bregante MA; Saez P; Aramayona JJ; Fraile L; Garcia MA; Solans C
    Am J Vet Res; 1999 Sep; 60(9):1111-6. PubMed ID: 10490081
    [TBL] [Abstract][Full Text] [Related]  

  • 66. New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits.
    Täuber MG; Hackbarth CJ; Scott KG; Rusnak MG; Sande MA
    Antimicrob Agents Chemother; 1985 Mar; 27(3):340-2. PubMed ID: 3838872
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacokinetics and tissue penetration of the new fluoroquinolone grepafloxacin.
    Child J; Andrews JM; Wise R
    Antimicrob Agents Chemother; 1995 Feb; 39(2):513-5. PubMed ID: 7726523
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Metabolic disposition of the new fluoroquinolone antibacterial agent DW116 in rats.
    Park YH; Jung BH; Chung BC; Park J; Mitoma C
    Drug Metab Dispos; 1997 Sep; 25(9):1101-3. PubMed ID: 9311628
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Grepafloxacin--a new fluoroquinolone.
    Med Lett Drugs Ther; 1998 Jan; 40(1019):17-8. PubMed ID: 9465856
    [No Abstract]   [Full Text] [Related]  

  • 70. Experimental pneumococcal meningitis. Permeability changes influencing the concentration of sugars and macromolecules in cerebrospinal fluid.
    Prockop LD; Fishman RA
    Arch Neurol; 1968 Nov; 19(5):449-63. PubMed ID: 5684296
    [No Abstract]   [Full Text] [Related]  

  • 71. Importance of Peptide transporter 2 on the cerebrospinal fluid efflux kinetics of glycylsarcosine characterized by nonlinear mixed effects modeling.
    Huh Y; Hynes SM; Smith DE; Feng MR
    Pharm Res; 2013 May; 30(5):1423-34. PubMed ID: 23371515
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Safety profile of grepafloxacin compared with other fluoroquinolones.
    Stahlmann R; Schwabe R
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():83-92. PubMed ID: 9484877
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lung tissue distribution after intravenous administration of grepafloxacin: comparative study with levofloxacin.
    Yamamoto H; Koizumi T; Hirota M; Kaneki T; Ogasawara H; Yamazaki Y; Fujimoto K; Kubo K
    Jpn J Pharmacol; 2002 Jan; 88(1):63-8. PubMed ID: 11855679
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.
    Nau R; Zysk G; Schmidt H; Fischer FR; Stringaris AK; Stuertz K; Brück W
    J Antimicrob Chemother; 1997 Jun; 39(6):781-8. PubMed ID: 9222048
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Penetration of enrofloxacin and ciprofloxacin into breast milk, and pharmacokinetics of the drugs in lactating rabbits and neonatal offspring.
    Aramayona JJ; Mora J; Fraile LJ; García MA; Abadía AR; Bregante MA
    Am J Vet Res; 1996 Apr; 57(4):547-53. PubMed ID: 8712523
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Determination of grepafloxacin in plasma and urine by a simple and rapid high-performance liquid chromatographic method.
    Kamberi M; Kamberi P; Nakano S
    J Chromatogr B Biomed Sci Appl; 2000 May; 741(2):295-300. PubMed ID: 10872599
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rifampin for therapy of experimental pneumococcal meningitis in rabbits.
    Nau R; Kaye K; Sachdeva M; Sande ER; Täuber MG
    Antimicrob Agents Chemother; 1994 May; 38(5):1186-9. PubMed ID: 8067762
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Grepafloxacin (Raxar)].
    Friis HM
    Ugeskr Laeger; 1998 Jul; 160(30):4438-41. PubMed ID: 9691842
    [No Abstract]   [Full Text] [Related]  

  • 79. Nitric oxide concentrations and cerebrospinal fluid parameters in an experimental animal model of Streptococcus pneumoniae meningitis.
    Destache CJ; Pakiz CB; Dash AK; Larsen C
    Pharmacotherapy; 1998; 18(3):612-9. PubMed ID: 9620112
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacokinetics of cefamandole and ampicillin in experimental meningitis.
    Beaty HN; Walters E
    Antimicrob Agents Chemother; 1979 Nov; 16(5):584-8. PubMed ID: 525998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.